The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2018-03-01
Sarja:Pharmacogenomics and Personalized Medicine
Aiheet:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Linkit:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia